I Mab Performance

IMABDelisted Stock  USD 3.98  0.02  0.51%   
The firm retains a Market Volatility (i.e., Beta) of 1.02, which attests to a somewhat significant risk relative to the market. I Mab returns are very sensitive to returns on the market. As the market goes up or down, I Mab is expected to follow. At this point, I Mab has a negative expected return of -0.22%. Please make sure to check out I Mab's jensen alpha, maximum drawdown, semi variance, as well as the relationship between the sortino ratio and potential upside , to decide if I Mab performance from the past will be repeated sooner or later.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days I Mab has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2026. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
Begin Period Cash Flow2.2 B
Total Cashflows From Investing Activities-136 M
  

I Mab Relative Risk vs. Return Landscape

If you would invest  455.00  in I Mab on October 30, 2025 and sell it today you would lose (57.00) from holding I Mab or give up 12.53% of portfolio value over 90 days. I Mab is currently does not generate positive expected returns and assumes 4.0752% risk (volatility on return distribution) over the 90 days horizon. In different words, 36% of stocks are less volatile than IMAB, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days I Mab is expected to under-perform the market. In addition to that, the company is 5.4 times more volatile than its market benchmark. It trades about -0.05 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.07 per unit of volatility.

I Mab Target Price Odds to finish over Current Price

The tendency of IMAB Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 3.98 90 days 3.98 
about 75.8
Based on a normal probability distribution, the odds of I Mab to move above the current price in 90 days from now is about 75.8 (This I Mab probability density function shows the probability of IMAB Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.02 . This usually indicates I Mab market returns are sensitive to returns on the market. As the market goes up or down, I Mab is expected to follow. Additionally I Mab has an alpha of 0.3115, implying that it can generate a 0.31 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   I Mab Price Density   
       Price  

Predictive Modules for I Mab

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as I Mab. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.193.857.93
Details
Intrinsic
Valuation
LowRealHigh
0.193.847.92
Details
Naive
Forecast
LowNextHigh
0.174.258.32
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
3.644.074.51
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as I Mab. Your research has to be compared to or analyzed against I Mab's peers to derive any actionable benefits. When done correctly, I Mab's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in I Mab.

I Mab Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. I Mab is not an exception. The market had few large corrections towards the I Mab's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold I Mab, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of I Mab within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.31
β
Beta against Dow Jones1.02
σ
Overall volatility
0.60
Ir
Information ratio 0.05

I Mab Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of I Mab for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for I Mab can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
I Mab is now traded under the symbol NBP. Please update your portfolios or report it if you believe this is an error. Report It!
I Mab is not yet fully synchronised with the market data
I Mab generated a negative expected return over the last 90 days
I Mab has high historical volatility and very poor performance
I Mab has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (49.7 M) with profit before overhead, payroll, taxes, and interest of 41.59 M.
I Mab currently holds about 3.92 B in cash with (52.67 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 47.2, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 21.0% of the company shares are held by company insiders

I Mab Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of IMAB Stock often depends not only on the future outlook of the current and potential I Mab's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. I Mab's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding81.2 M
Cash And Short Term Investments173.4 M

I Mab Fundamentals Growth

IMAB Stock prices reflect investors' perceptions of the future prospects and financial health of I Mab, and I Mab fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on IMAB Stock performance.

About I Mab Performance

By analyzing I Mab's fundamental ratios, stakeholders can gain valuable insights into I Mab's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if I Mab has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if I Mab has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. The company was founded in 2014 and is headquartered in Shanghai, the Peoples Republic of China. I-Mab ADR operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 378 people.

Things to note about I Mab performance evaluation

Checking the ongoing alerts about I Mab for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for I Mab help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
I Mab is now traded under the symbol NBP. Please update your portfolios or report it if you believe this is an error. Report It!
I Mab is not yet fully synchronised with the market data
I Mab generated a negative expected return over the last 90 days
I Mab has high historical volatility and very poor performance
I Mab has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (49.7 M) with profit before overhead, payroll, taxes, and interest of 41.59 M.
I Mab currently holds about 3.92 B in cash with (52.67 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 47.2, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 21.0% of the company shares are held by company insiders
Evaluating I Mab's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate I Mab's stock performance include:
  • Analyzing I Mab's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether I Mab's stock is overvalued or undervalued compared to its peers.
  • Examining I Mab's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating I Mab's management team can have a significant impact on its success or failure. Reviewing the track record and experience of I Mab's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of I Mab's stock. These opinions can provide insight into I Mab's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating I Mab's stock performance is not an exact science, and many factors can impact I Mab's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Consideration for investing in IMAB Stock

If you are still planning to invest in I Mab check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the I Mab's history and understand the potential risks before investing.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets